← Back
$MIRM All transactions

Mirum Pharmaceuticals, Inc.

A

$ Value

$0

Shares

6,268

Price

$0

Filed

Jun 2

Insider

Name

GREY MICHAEL G

Title

CIK

0001240122

Roles

Director

Transaction Details

Transaction Date

2025-05-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,268

Footnotes

The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. | Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer.

Filing Info

Accession No.

0001415889-25-015304

Form Type

4

Issuer CIK

0001759425

GREY MICHAEL G's History

Date Ticker Type Value
2025-12-19 MIRM M $147K
2025-12-19 MIRM $3.9M
2025-12-19 MIRM M $0
2025-12-11 SPRB A
2025-12-11 SPRB D
2025-12-11 SPRB A
2025-12-11 SPRB D
2025-12-11 SPRB A
2025-12-11 SPRB D
2025-12-11 SPRB A

Other Insiders at MIRM (90d)

Insider Bought Sold Last
Heron Patrick J $9.0M 2026-01-23
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
$101K 2026-01-28
Ramasastry Saira $194K 2026-04-15
Peetz Christopher
CHIEF EXECUTIVE OFFICER
$1.6M 2026-02-02
Radovich Peter
PRESIDENT AND COO
$574K 2026-02-02
Quan Joanne
CHIEF MEDICAL OFFICER
2026-01-28
Howe Jolanda
SVP, GLOBAL CONTROLLER
$181K 2026-02-02